A novel concept for partial liver transplantation in nonresectable colorectal liver metastases: The RAPID concept

Annals of Surgery

Volumn 262, Issue 1, 2015, Pages e5-e9

  Line, Pål Dag ^a   Hagness, Morten ^a   Berstad, Audun Elnaes ^a   Foss, Aksel ^a,b   Dueland, Svein ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

2 staged hepatectomy; Auxiliary liver transplantation; Colorectal cancer; Liver metastases

Indexed keywords

ALANINE AMINOTRANSFERASE; AMINOTRANSFERASE; BILIRUBIN; CETUXIMAB; FLUOROURACIL; IRINOTECAN;

ADULT; ADVANCED CANCER; ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; CANCER SURVIVAL; CASE REPORT; CLINICAL PROTOCOL; COLONOSCOPY; COLORECTAL LIVER METASTASIS; COMPUTER ASSISTED TOMOGRAPHY; GROWTH RATE; HEPATOJEJUNOSTOMY; HUMAN; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER FUNCTION; LIVER GRAFT; LIVER SURGERY; LIVER TRANSPLANTATION; LIVER VEIN; LIVER WEIGHT; LIVING DONOR; MALE; MIDDLE AGED; PARTIAL LIVER TRANSPLANTATION; PATIENT SAFETY; PORTAL VEIN BLOOD FLOW; PORTAL VEIN BLOOD PRESSURE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTO ONCOGENE; RECTUM CANCER; SURVIVAL RATE; URETEROSIGMOIDOSTOMY; VIRUS ONCOGENE; ADENOCARCINOMA; ADJUVANT CHEMORADIOTHERAPY; ADJUVANT THERAPY; ADVERSE EFFECTS; ALLOTRANSPLANTATION; LIVER; LIVER NEOPLASMS; LIVER REGENERATION; LIVER RESECTION; ORGAN SIZE; PATHOLOGY; PATHOPHYSIOLOGY; PORTAL VEIN; PROCEDURES; RECTAL NEOPLASMS; SECONDARY; TREATMENT OUTCOME; VASCULARIZATION;

ADENOCARCINOMA; CHEMORADIOTHERAPY, ADJUVANT; HEPATECTOMY; HUMANS; LIVER; LIVER FAILURE; LIVER NEOPLASMS; LIVER REGENERATION; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; ORGAN SIZE; PORTAL VEIN; RECTAL NEOPLASMS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 84939423834     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000001165     Document Type: Article

References (19)

1. Adam R, Laurent A, Azoulay D, et al. Two-stage hepatectomy: a planned strategy to treat irresectable liver tumors. Ann Surg. 2000;232:777-785.
2. Hemming A, Reed A, Howard R, et al. Preoperative portal vein emboliza-tion for extended hepatectomy. Ann Surg. 2003;237:686-691; discussion 691-693.
3. Jaeck D, Oussoultzoglou E, Rosso E, et al. A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases. Ann Surg. 2004;240:1037-1049; discussion 1049-1051.
4. Hagness M, Foss A, Line P-D, et al. Liver transplantation for nonresectable liver metastases from colorectal cancer. Ann Surg. 2013;257:800-806.
5. Dueland S, Guren TK, Hagness M, et al. Chemotherapy or liver transplantation for nonresectable liver metastases from colorectal cancer? Ann Surg. 19 June 2014. [ePub ahead of print]
6. Hagness M, Foss A, Egge TS, et al. Patterns of recurrence after liver transplantation for nonresectable liver metastases from colorectal cancer. Ann Surg Oncol. 2014;21:1323-1329.
7. Shindoh J, Loyer EM, Kopetz S, et al. Optimal morphologic response to pre-operative chemotherapy: an alternate outcome end point before resection of hepatic colorectal metastases. J Clin Oncol. 2012;30:4566-4572.
8. Renz JF, Yersiz H, Reichert PR, et al. Split-liver transplantation: a review. Am J Transplant. 2003;3:1323-1335.
9. Heaton N, Srinivasan P, Prachalias A, et al. Overcoming the limitations of living donor and split liver transplantation: a proposal for adult recipients (the best of the East in the West). Liver Transpl. 2008;14:932-934.
10. Heaton N. Small-for-size liver syndrome after auxiliary and split liver transplantation: donor selection. Liver Transpl. 2003;9:S26-S28.
11. Ito T, Kiuchi T, Yamamoto H, et al. Changes in portal venous pressure in the early phase after living donor liver transplantation: pathogenesis and clinical implications. Transplantation. 2003;75:1313-1317.
12. Takada Y, Ueda M, Ishikawa Y, et al. End-to-side portocaval shunting for a small-for-size graft in living donor liver transplantation. Liver Transpl. 2004;10:807-810.
13. Allard M-A, Adam R, Bucur P-O, et al. Posthepatectomy portal vein pressure predicts liver failure and mortality after major liver resection on noncirrhotic liver. Ann Surg. 2013;258:822-829; discussion 829-830.
14. Heinemann A, Wischhusen F, Püschel K, et al. Standard liver volume in the Caucasian population. Liver Transpl Surg. 1999;5:366-368.
15. Dindo D, Demartines N, Clavien P-A. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205-213.
16. Dokmak S, Elkrief L, Belghiti J. Auxiliary liver transplantation with a small deceased liver graft for cirrhotic liver complicated by hepatocellular carcinoma. Transpl Int. 2013;26:e102-e104.
17. Schlegel A, Lesurtel M, Melloul E, et al. ALPPS: from human to mice highlighting accelerated and novel mechanisms of liver regeneration. Ann Surg. 2014;260:839-847.
18. Clavien P-A, Petrowsky H, DeOliveira ML, et al. Strategies for safer liver surgery and partial liver transplantation. N Engl J Med. 2007;356:1545-1559.
19. Barkun JS, Aronson JK, Feldman LS, et al. Evaluation and stages of surgical innovations. The Lancet. 2009;374:1089-1096.